Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in South Africa 
      • Strategy 
      • Diversity and Inclusion 
      • People and Culture 
      • PAIA Manuals 
      • Contacts 
      Scientist in laboratory
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Patient Support and Engagement 
      • Discovery & development 
      A couple holding hands
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      • Grants & Sponsorships 
      A female doctor looking in the distance
      Healthcare Professionals
    • ESG 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Corporate Responsibility 
      Young patients waiting outside hospital in Rwanda
      ESG
    • News 
      • Recent News 
      • News Archive 
      • Stories 
      • Contacts 
      A photo of people in a meeting hall
      News
    • Careers 
      • Career Search 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity and Inclusion 
      • Employee Benefits 
      • Awards & Recognition 
      Search jobs
      Careers
    • Coronavirus 
      Coronavirus
    Novartis South Africa building
    Home

News Archive

Date Range
News Archive Navigation
  • All
  • Media Release
  • Featured News
icon
Showing 5 results

May 2020

  • Media Release May 06, 2020

    Novartis pledges its support during COVID-19 Pandemic

    Novartis SA has donated R13,3 million to two local NGO’s as its contribution towards alleviating the socio-economic pressures currently being experienced by South Africans due to the COVID-19…

July 2019

  • Featured News Jul 18, 2019

    Novartis introduces pioneering equal parental leave policy in South Africa

  • Featured News Jul 15, 2019

    Clicks Helping Hand Trust and Novartis donate sanitary towels to school children for World Menstrual Hygiene Day

October 2018

  • Media Release Oct 25, 2018

    Novartis Donates One Million Rands Worth of Medicines Towards Cholera Outbreak in Zimbabwe

    Collaboration of government, industry and NGO’s vital for minimization and eradication of healthcare challenges Harare, 12 October, 2018 – Novartis has made a donation of medicines to the value…

June 2018

  • Media Release Jun 05, 2018

    Novartis brings over US$149 million GDP benefits to SA

    In addition to extensive medical benefits, Novartis contributes nearly US$150 million to SA’s GDP Ongoing efforts to build SA scientific capacity, boost local healthcare Johannesburg, 04 June,…

Pagination

Novartis South Africa

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Novartis South Africa
  • Global site
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Cookie
  • Site Map
Novartis Site Directory
This site is intended to South African Republic audience